...
search icon
tbio-img

Telesis Bio Inc., Common Stock

TBIO

PINK

$0.92

-$0.06

(-6.12%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.64M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.95K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.25 L
$7.29 H
$0.92

About Telesis Bio Inc., Common Stock

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameTBIOSectorS&P500
1-Week Return-10.91%0.44%0.24%
1-Month Return226.67%-7.69%-7.32%
3-Month Return133.33%-3.35%-12.05%
6-Month Return-61.57%-11.09%-9.73%
1-Year Return-85.67%-2.13%5.05%
3-Year Return-98.66%-1.18%20.03%
5-Year Return-99.71%34.44%83.31%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue4.80M6.58M11.04M27.43M27.51M[{"date":"2019-12-31","value":17.47,"profit":true},{"date":"2020-12-31","value":23.9,"profit":true},{"date":"2021-12-31","value":40.14,"profit":true},{"date":"2022-12-31","value":99.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue8.89M2.95M6.74M11.84M10.56M[{"date":"2019-12-31","value":75.08,"profit":true},{"date":"2020-12-31","value":24.92,"profit":true},{"date":"2021-12-31","value":56.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.18,"profit":true}]
Gross Profit(4.08M)3.63M4.30M15.60M16.95M[{"date":"2019-12-31","value":-24.09,"profit":false},{"date":"2020-12-31","value":21.39,"profit":true},{"date":"2021-12-31","value":25.36,"profit":true},{"date":"2022-12-31","value":92.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(84.99%)55.12%38.93%56.84%61.62%[{"date":"2019-12-31","value":-137.94,"profit":false},{"date":"2020-12-31","value":89.46,"profit":true},{"date":"2021-12-31","value":63.18,"profit":true},{"date":"2022-12-31","value":92.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses2.89M19.99M39.67M62.08M63.49M[{"date":"2019-12-31","value":4.56,"profit":true},{"date":"2020-12-31","value":31.48,"profit":true},{"date":"2021-12-31","value":62.49,"profit":true},{"date":"2022-12-31","value":97.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(6.98M)(16.36M)(35.37M)(46.48M)(46.54M)[{"date":"2019-12-31","value":-697600000,"profit":false},{"date":"2020-12-31","value":-1636100000,"profit":false},{"date":"2021-12-31","value":-3537400000,"profit":false},{"date":"2022-12-31","value":-4648500000,"profit":false},{"date":"2023-12-31","value":-4653900000,"profit":false}]
Total Non-Operating Income/Expense-(2.33M)(4.94M)(3.18M)(2.69M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-233400000,"profit":false},{"date":"2021-12-31","value":-493900000,"profit":false},{"date":"2022-12-31","value":-317900000,"profit":false},{"date":"2023-12-31","value":-268900000,"profit":false}]
Pre-Tax Income(8.30M)(18.00M)(38.94M)(48.45M)(47.70M)[{"date":"2019-12-31","value":-830200000,"profit":false},{"date":"2020-12-31","value":-1800500000,"profit":false},{"date":"2021-12-31","value":-3894400000,"profit":false},{"date":"2022-12-31","value":-4844700000,"profit":false},{"date":"2023-12-31","value":-4770000000,"profit":false}]
Income Taxes(486.00K)5.00K14.00K24.00K24.00K[{"date":"2019-12-31","value":-2025,"profit":false},{"date":"2020-12-31","value":20.83,"profit":true},{"date":"2021-12-31","value":58.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-(18.01M)(38.96M)(48.47M)(47.72M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1801000000,"profit":false},{"date":"2021-12-31","value":-3895800000,"profit":false},{"date":"2022-12-31","value":-4847100000,"profit":false},{"date":"2023-12-31","value":-4772400000,"profit":false}]
Income From Continuous Operations-(18.01M)(38.96M)(48.47M)(38.17M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1801000000,"profit":false},{"date":"2021-12-31","value":-3895800000,"profit":false},{"date":"2022-12-31","value":-4847100000,"profit":false},{"date":"2023-12-31","value":-3816900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.30M)(18.01M)(38.96M)(48.47M)(47.72M)[{"date":"2019-12-31","value":-830200000,"profit":false},{"date":"2020-12-31","value":-1801000000,"profit":false},{"date":"2021-12-31","value":-3895800000,"profit":false},{"date":"2022-12-31","value":-4847100000,"profit":false},{"date":"2023-12-31","value":-4772400000,"profit":false}]
EPS (Diluted)(2.20)(0.81)(2.17)(1.65)(1.25)[{"date":"2019-12-31","value":-220,"profit":false},{"date":"2020-12-31","value":-81,"profit":false},{"date":"2021-12-31","value":-217,"profit":false},{"date":"2022-12-31","value":-165,"profit":false},{"date":"2023-12-31","value":-125,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TBIO
Cash Ratio 0.68
Current Ratio 1.23
Quick Ratio 1.06

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TBIO
ROA (LTM) -30.10%
ROE (LTM) -178.99%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TBIO
Debt Ratio Lower is generally better. Negative is bad. 0.84
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.16

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TBIO
Trailing PE NM
Forward PE NM
P/S (TTM) 0.10
P/B 1.11
Price/FCF NM
EV/R 2.94
EV/Ebitda NM

FAQs

What is Telesis Bio Inc. share price today?

Telesis Bio Inc. (TBIO) share price today is $0.92

Can Indians buy Telesis Bio Inc. shares?

Yes, Indians can buy shares of Telesis Bio Inc. (TBIO) on Vested. To buy Telesis Bio Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Telesis Bio Inc. be purchased?

Yes, you can purchase fractional shares of Telesis Bio Inc. (TBIO) via the Vested app. You can start investing in Telesis Bio Inc. (TBIO) with a minimum investment of $1.

How to invest in Telesis Bio Inc. shares from India?

You can invest in shares of Telesis Bio Inc. (TBIO) via Vested in three simple steps:

  • Click on Sign Up or Invest in TBIO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Telesis Bio Inc. shares
What is Telesis Bio Inc. 52-week high and low stock price?

The 52-week high price of Telesis Bio Inc. (TBIO) is $7.29. The 52-week low price of Telesis Bio Inc. (TBIO) is $0.25.

What is Telesis Bio Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Telesis Bio Inc. (TBIO) is 1.11

What is the Market Cap of Telesis Bio Inc.?

The market capitalization of Telesis Bio Inc. (TBIO) is $1.64M

What is Telesis Bio Inc.’s stock symbol?

The stock symbol (or ticker) of Telesis Bio Inc. is TBIO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top